Literature DB >> 28332010

An evidence-based walking program among older people with knee osteoarthritis: the PEP (participant exercise preference) pilot randomized controlled trial.

Laurianne Loew1, Lucie Brosseau2, Glen P Kenny3,4, Natalie Durand-Bush3, Stéphane Poitras2, Gino De Angelis2, George A Wells5.   

Abstract

Knee osteoarthritis is a common joint problem leading to an increase of pain and a loss of function in older individuals. The main objective of this study was to evaluate if a participant who was randomly assigned to his preferred group improved his adherence to an effective walking program compared to a participant who did not receive his preferred group. This was a 9-month pilot randomized clinical trial, based on a patient treatment preferences design. The 69 eligible participants had a diagnosis of knee osteoarthritis. Participants were randomized to one of two groups: a supervised community-based or unsupervised walking program, based on the Ottawa Panel guidelines. At 6 months, participants who expressed a preference, either for the supervised or unsupervised program, and who were assigned to their preferred choice of program showed significantly higher adherence to walking sessions (supervised 60.7 ± 12.3%, P < 0.0001; unsupervised 43.1 ± 12.1%, P = 0.03), compared to the participants who did not obtain their preferred choice of program. After 9 months, significant improvements were shown according to the level of stiffness evaluated with the WOMAC (P = 0.01) and the functional status assessed with the Timed Up and GO Test (P = 0.04), among the adherent participants who obtained their preference, as compared to those who did not receive their preference. We show this approach promotes long-term adherence to a community-based walking program, while ensuring the maintenance of clinical benefits of walking, among older adults susceptible to avoid or not properly engage in physical activity.

Entities:  

Keywords:  Clinical trials; Implementation; Knee; Osteoarthritis; Preference; Walking

Mesh:

Year:  2017        PMID: 28332010     DOI: 10.1007/s10067-017-3606-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  A SIMPLE FIELD TEST FOR THE ASSESSMENT OF PHYSICAL FITNESS. REP 63-6.

Authors:  B BALKE
Journal:  Rep Civ Aeromed Res Inst US       Date:  1963-04

2.  What influences participants' treatment preference and can it influence outcome? Results from a primary care-based randomised trial for shoulder pain.

Authors:  Elaine Thomas; Peter R Croft; Susan M Paterson; Krysia Dziedzic; Elaine M Hay
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

Review 3.  Ottawa panel evidence-based clinical practice guidelines for aerobic walking programs in the management of osteoarthritis.

Authors:  Laurianne Loew; Lucie Brosseau; George A Wells; Peter Tugwell; Glen P Kenny; Robert Reid; Andreas Maetzel; Maria Huijbregts; Carolyn McCullough; Gino De Angelis; Douglas Coyle
Journal:  Arch Phys Med Rehabil       Date:  2012-03-12       Impact factor: 3.966

4.  Exercise, self-efficacy, and mobility performance in overweight and obese older adults with knee osteoarthritis.

Authors:  Brian C Focht; W Jack Rejeski; Walter T Ambrosius; Jeffrey A Katula; Stephen P Messier
Journal:  Arthritis Rheum       Date:  2005-10-15

5.  Physical activity assessment methodology in the Five-City Project.

Authors:  J F Sallis; W L Haskell; P D Wood; S P Fortmann; T Rogers; S N Blair; R S Paffenbarger
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897

6.  A randomized trial comparing a group exercise programme for back pain patients with individual physiotherapy in a severely deprived area.

Authors:  Jane L Carr; Jennifer A Klaber Moffett; Elaine Howarth; Stewart J Richmond; David J Torgerson; David A Jackson; Caroline J Metcalfe
Journal:  Disabil Rehabil       Date:  2005-08-19       Impact factor: 3.033

7.  Clinically important improvement in function is common in people with or at high risk of knee OA: the MOST study.

Authors:  Daniel K White; Julie J Keysor; Michael P Lavalley; Cora E Lewis; James C Torner; Michael C Nevitt; David T Felson
Journal:  J Rheumatol       Date:  2010-04-15       Impact factor: 4.666

Review 8.  Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.

Authors:  Joanne L Jordan; Melanie A Holden; Elizabeth Ej Mason; Nadine E Foster
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  The implementation of a community-based aerobic walking program for mild to moderate knee osteoarthritis: a knowledge translation randomized controlled trial: part II: clinical outcomes.

Authors:  Lucie Brosseau; George A Wells; Glen P Kenny; Robert Reid; Andreas Maetzel; Peter Tugwell; Maria Huijbregts; Carolyn McCullough; Gino De Angelis; Lily Chen
Journal:  BMC Public Health       Date:  2012-12-12       Impact factor: 3.295

Review 10.  Patients' preferences within randomised trials: systematic review and patient level meta-analysis.

Authors: 
Journal:  BMJ       Date:  2008-10-31
View more
  3 in total

1.  Short-Term Effects of Strengthening Exercises of the Lower Limb Rehabilitation Protocol on Pain, Stiffness, Physical Function, and Body Mass Index among Knee Osteoarthritis Participants Who Were Overweight or Obese: A Clinical Trial.

Authors:  Muhammad Tariq Rafiq; Mohamad Shariff A Hamid; Eliza Hafiz
Journal:  ScientificWorldJournal       Date:  2021-12-22

2.  Is high-intensity interval cycling feasible and more beneficial than continuous cycling for knee osteoarthritic patients? Results of a randomised control feasibility trial.

Authors:  Justin W Keogh; Josephine Grigg; Christopher J Vertullo
Journal:  PeerJ       Date:  2018-05-09       Impact factor: 2.984

3.  A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis.

Authors:  Graham Boniface; Varsha Gandhi; Meriel Norris; Esther Williamson; Shona Kirtley; Neil E O'Connell
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.